| HGNC Family | Non-coding RNAs |
| Name | microRNA 1285-2 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nResearch across diverse pathological contexts indicates that MIR1285‐2, a member of the miR‐1285 family, functions predominantly as a tumor suppressor. For instance, in lung squamous cell carcinoma, comprehensive miRNA profiling identified differentially expressed miRNAs that hold promise as early biomarkers, suggesting a potential role for MIR1285‐2 in early detection and outcome prediction."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In pancreatic ductal adenocarcinoma, downregulation of miR‐1285 is associated with enhanced cell proliferation and chemoresistance; restoration of its levels suppressed oncogenic signals—including YAP1, EGFR, and β‐catenin—and increased gemcitabine sensitivity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Similarly, in breast cancer, lower expression of miR‐1285‐5p correlates with poor prognosis; overexpression inhibited cell proliferation, and mechanistic studies revealed that miR‐1285–mediated suppression of targets such as TMEM194A disrupts centrosome dynamics."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Further extending its role in oncogenesis, network analyses have implicated a circular RNA (hsa_circ_0000376) acting as a sponge for miR‐1285‐3p, thereby modulating the expression of genes like SMURF1, BTRC, and TP53 involved in cell cycle and apoptosis regulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its involvement in cancer, MIR1285‐2 appears to play critical roles in other disease states. In type 2 diabetes, miR‐1285 has emerged as a novel prognostic, diagnostic, and therapeutic target, with its modulation potentially affecting key cellular processes and signaling pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Additionally, in ocular pathology, particularly in a rabbit model of proliferative vitreoretinopathy, overexpression of miR‐1285 counteracted TGF‐β2–induced epithelial–mesenchymal transition (EMT) by directly targeting Smad4, thereby alleviating EMT features such as aberrant cell migration and contractility."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Collectively, these studies underscore the multifaceted role of MIR1285‐2 in regulating cellular proliferation, motility, and response to injury, highlighting its potential as both a biomarker and a therapeutic target in a range of pathological settings.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xujie Gao, Yang Wang, Hua Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.11198"}], "href": "https://doi.org/10.18632/oncotarget.11198"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27517633"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27517633"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "H Huang, G Xiong, P Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-1285 inhibits malignant biological behaviors of human pancreatic cancer cells by negative regulation of YAP1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasma (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4149/neo_2017_306"}], "href": "https://doi.org/10.4149/neo_2017_306"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28253715"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28253715"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Ai Hironaka-Mitsuhashi, Kurataka Otsuka, Luc Gailhouste, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-1285-5p/TMEM194A axis affects cell proliferation in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.14287"}], "href": "https://doi.org/10.1111/cas.14287"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31854049"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31854049"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Ziqi Peng, Boyang Xu, Feng Jin "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Technol Cancer Res Treat (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1533033820928471"}], "href": "https://doi.org/10.1177/1533033820928471"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32462972"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32462972"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Lian Bai, Junwu Li, Mani Panagal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation dependent microRNA 1285-5p and sterol carrier proteins 2 in type 2 diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Artif Cells Nanomed Biotechnol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21691401.2019.1652625"}], "href": "https://doi.org/10.1080/21691401.2019.1652625"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31407919"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31407919"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Shu-I Pao, Le-Tien Lin, Yi-Hao Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Repression of Smad4 by MicroRNA-1285 moderates TGF-β-induced epithelial-mesenchymal transition in proliferative vitreoretinopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0254873"}], "href": "https://doi.org/10.1371/journal.pone.0254873"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34383767"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34383767"}]}]}]}
|
| Synonyms | HSA-MIR-1285-2, MIRN1285-2 |
| NCBI Gene ID | 100302268 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR1285-2 has 103 functional associations with biological entities spanning 1 categories (cell line, cell type or tissue) extracted from 1 datasets.
Click the + buttons to view associations for MIR1285-2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR1285-2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |